Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone CLB-IVC7] (IgG1) to Human CD36
Mouse Monoclonal [clone CB38 (NL07)] (IgM) to Human CD36
Human (tested or 100% immunogen sequence identity)
IgM Monoclonal [CB38 (NL07)]
Specificity and Use
CD36 antibody was raised against living human myeloid cells.
Monoclonal antibody CB38 (NL07) recognizes CD36 (GPIIIb), a 85-113 kD integral membrane glycoprotein expressed on platelets, macrophages, endothelial cells, early erythroid cells and megakaryocytes.
The reagent is designed for Flow Cytometry analysis of human blood cells using 4 ul reagent / 100 ul of whole blood or 106 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
PBS, 0.2% BSA, 0.02% sodium azide.
Store in the dark at 2-8 C. Do not freeze. Avoid prolonged exposure to light.
Binds to collagen, thrombospondin, anionic phospholipids and oxidized low-density lipoprotein (oxLDL). May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic effects.